n-(3-(aminomethyl)benzyl)acetamidine has been researched along with ml 7 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Biały, D; Bil-Lula, I; Diebel, L; Lin, HB; Sawicka, J; Sawicki, G; Wawrzyńska, M; Woźniak, M | 1 |
1 other study(ies) available for n-(3-(aminomethyl)benzyl)acetamidine and ml 7
Article | Year |
---|---|
Subthreshold nitric oxide synthase inhibition improves synergistic effects of subthreshold MMP-2/MLCK-mediated cardiomyocyte protection from hypoxic injury.
Topics: Animals; Azepines; Cardiotonic Agents; Cell Hypoxia; Doxycycline; Drug Synergism; Enzyme Inhibitors; Imines; Immunoblotting; Male; Matrix Metalloproteinase 2; Myocardial Contraction; Myocytes, Cardiac; Myosin-Light-Chain Kinase; Naphthalenes; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Oxygen; Rats, Sprague-Dawley | 2016 |